Panqi Fang on Muck Rack

Panqi Fang

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Panqi

Contact Panqi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Impact of quality control indicator system management program on neoadjuvant and adjuvant therapies for breast cancer: a comparative analysis

|
By Silu Xu, Lili Zhang, Sainan Hu, Haijuan Gu, Zeng Chen, Zhengzheng Xie, Nan Wu, Yuanyuan Wen, Xin L. Liu, Xinwei Dong, Yiming Jiang, Dan Yan, Nianyang Ding, Meixin Ni, Panqi Fang
| Frontiers
1 Introduction Breast cancer (BC) is the most prevalent malignant tumor worldwide. In 2020, its global incidence was 2.26 million, accounting for approximately 11.7% of global cancer incidence (1). In 2022, BC ranked first among female malignant tumors in China, with an incidence of 357,200 and a mortality of 75,000 (2). Subsequently, this disease represents a major health threat to women in China.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified